Work

Timing of US Food and Drug Administration (FDA) cancer drug approvals relative to publication of clinical trial results.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.2071

Authors: Ali Raza Khaki, Aakash Desai, Martin W. Schoen, Bishal Gyawali, Eddy J. Chen, Peter C. Yang, Jeremy Lyle Warner

Institutions: University of Washington, UConn Health, Saint Louis University, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Massachusetts General Hospital, Vanderbilt University, Vanderbilt-Ingram Cancer Center

Language: English

Topic: Pharmaceutical industry and healthcare

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W3031453520

Cites:

Cited by: 2

Related to: 10